A survey of surgical management of the sentinel node positive melanoma patient in the post‐MSLT2 era

2021 ◽  
Author(s):  
Jennifer S. Downs ◽  
Suren Subramaniam ◽  
Michael A. Henderson ◽  
Elizabeth Paton ◽  
Andrew J. Spillane ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Surgical Management ◽  
Melanoma Patient ◽  
Node Positive

Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations

2018 ◽  
Vol 96 ◽  
pp. 25-33 ◽  
Author(s):  
Daniëlle Verver ◽  
David van Klaveren ◽  
Alexander C.J. van Akkooi ◽  
Piotr Rutkowski ◽  
Barry W.E.M. Powell ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Risk Stratification ◽  
Sentinel Node ◽  
Surgical Management ◽  
Node Positive ◽  
Treatment Considerations ◽  
Melanoma Patients ◽  
Therapy Treatment

Risk stratification of sentinel node positive melanoma patients defines surgical management and adjuvant therapy treatment considerations

2019 ◽  
Vol 45 (2) ◽  
pp. e14
Author(s):  
D. Verver ◽  
D. van Klaveren ◽  
A. van Akkooi ◽  
P. Rutkowski ◽  
B. Powell ◽  
...  
Keyword(s):  
Adjuvant Therapy ◽  
Risk Stratification ◽  
Sentinel Node ◽  
Surgical Management ◽  
Node Positive ◽  
Treatment Considerations ◽  
Melanoma Patients ◽  
Therapy Treatment

scholarly journals Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2)

Cancer ◽  
2021 ◽  
Author(s):  
Kristy Kummerow Broman ◽  
Tasha Hughes ◽  
Lesly Dossett ◽  
James Sun ◽  
Dennis Kirichenko ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Active Surveillance ◽  
Node Positive ◽  
Selective Lymphadenectomy

Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system

2008 ◽  
Vol 62 (11) ◽  
pp. 1785-1791 ◽  
Author(s):  
B. Unal ◽  
A. S. Gur ◽  
O. Kayiran ◽  
R. Johnson ◽  
G. Ahrendt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Node ◽  
Scoring System ◽  
Node Positive ◽  
Sentinel Lymph Node Positivity ◽  
Positive Breast Cancer

Validation of the Louisville Breast Sentinel Node Prediction Models and a Proposed Modification to Guide Management of the Node Positive Axilla

2012 ◽  
Vol 78 (7) ◽  
pp. 761-765 ◽  
Author(s):  
Donald R. Lannin ◽  
Brigid Killelea ◽  
Nina Horowitz ◽  
Anees B. Chagpar
Keyword(s):  
Sentinel Node ◽  
Axillary Dissection ◽  
Prediction Models ◽  
Axillary Node ◽  
Positive Sentinel Node ◽  
Sentinel Nodes ◽  
Node Positive ◽  
Size Number ◽  
Node Involvement ◽  
Proposed Modification

The ACOSOG Z11 trial is rapidly changing use of axillary dissection, but it is not known how generalizable the Z11 results are. This study compares characteristics of the Z11 patients with the larger group of sentinel node-positive patients and evaluates two previously described Louisville algorithms to determine whether they might still be useful to predict extent of axillary node involvement and guide management of the axilla. The Yale Breast Center database was queried to calculate the Louisville prediction points for patients with a positive sentinel node and to compare the predicted with actual results. Of 1215 sentinel node biopsies performed between 2004 and 2010, 282 (23%) had at least one positive node. Thirty-one per cent of these patients would have been eligible for Z11. This group had much less axillary node involvement than the 69 per cent who were ineligible. The Yale data confirmed the accuracy of the two Louisville models and showed that tumor size, number of positive sentinel nodes, and proportion of positive sentinel nodes were all significant predictors. However, these results were much more robust if at least three sentinel nodes had been removed. The Z11 patients were clearly a good risk group. The data validate the two Louisville models and suggest that the models may be useful to select patients to avoid axillary dissection, both among the currently Z11-eligible and -ineligible populations. A modified algorithm is proposed in which all patients with a positive sentinel node have at least three total nodes removed.

Day-surgical Management of Ductal Carcinoma in Situ (Dcis) of the Breast Using Wide Local Excision with Sentinel Node Biopsy

2002 ◽  
Vol 88 (3) ◽  
pp. S48-S49 ◽  
Author(s):  
O Buonomo ◽  
AV Granai ◽  
A Felici ◽  
R Piccirillo ◽  
N De Liguori Carino ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Surgical Management ◽  
Local Excision ◽  
Ductal Carcinoma In Situ ◽  
Wide Local Excision ◽  
Carcinoma In Situ ◽  
Ductal Carcinoma ◽  
Node Biopsy

Prediction of nonsentinel lymph node metastasis in sentinel node–positive breast carcinoma

2007 ◽  
Vol 11 (1) ◽  
pp. 10-12 ◽  
Author(s):  
Umesh Kapur ◽  
Tara Rubinas ◽  
Ritu Ghai ◽  
James Sinacore ◽  
Katherine Yao ◽  
...  
Keyword(s):  
Lymph Node ◽  
Breast Carcinoma ◽  
Lymph Node Metastasis ◽  
Sentinel Node ◽  
Node Metastasis ◽  
Node Positive ◽  
Nonsentinel Lymph Node

scholarly journals Current management of patients with melanoma who are found to be sentinel node‐positive

2019 ◽  
Vol 90 (4) ◽  
pp. 491-496 ◽  
Author(s):  
Amanda A. G. Nijhuis ◽  
Andrew J. Spillane ◽  
Jonathan R. Stretch ◽  
Robyn P. M. Saw ◽  
Alexander M. Menzies ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Current Management ◽  
Node Positive

Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy

2019 ◽  
Vol 30 ◽  
pp. 1-5 ◽  
Author(s):  
Oscar Leopoldo Christin ◽  
Jonathan Kuten ◽  
Einat Even-Sapir ◽  
Joseph Klausner ◽  
Tehillah S. Menes
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Neoadjuvant Therapy ◽  
Node Positive ◽  
Pet Ct ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document